Exelixis

Latest articles

8d
FOX Business
4 Reasons Exelixis, Inc. More Than Doubled in 2017Shares of Exelixis(NASDAQ: EXEL), a biotech company focused on the development
FOX Business / Posted 8 days ago
Shares of Exelixis(NASDAQ: EXEL), a biotech company focused on the development of therapies to treat cancer, exploded higher by 104% in 2017, according to data from S&P Global Market Intelligence. The catalysts behind this move all tie in, some way... Read more
8d
FOX Business
4 Reasons Exelixis, Inc. More Than Doubled in 2017Continue Reading Below Shares of Exelixis(NASDAQ: EXEL), a biotech company foc
FOX Business / Posted 8 days ago
Continue Reading Below Shares of Exelixis(NASDAQ: EXEL), a biotech company focused on the development of therapies to treat cancer, exploded higher by 104% in 2017, according to data from S&P Global Market Intelligence. The catalysts behind this... Read more
14d
FOX Business
The Secret Sauce Behind Exelixis, Inc.'s 12% Move Higher in DecemberShares of Exelixis(NASDAQ: EXEL), a biopharmaceutical company focused on the de
FOX Business / Posted 14 days ago
Shares of Exelixis(NASDAQ: EXEL), a biopharmaceutical company focused on the development of drugs to fight cancer, continued an amazing two-year run by advancing another 12% during the month of December, according to data from S&P Global Market... Read more
14d
FOX Business
The Secret Sauce Behind Exelixis, Inc.'s 12% Move Higher in DecemberContinue Reading Below Shares of Exelixis(NASDAQ: EXEL), a biopharmaceutical c
FOX Business / Posted 14 days ago
Continue Reading Below Shares of Exelixis(NASDAQ: EXEL), a biopharmaceutical company focused on the development of drugs to fight cancer, continued an amazing two-year run by advancing another 12% during the month of December, according to data from... Read more
28d
FOX Business
Why Exelixis, Inc. Could Be a Gold Mine for Growth InvestorsExelixis, Inc.(NASDAQ: EXEL) has already delivered big gains this year, but the
FOX Business / Posted 28 days ago
Exelixis, Inc.(NASDAQ: EXEL) has already delivered big gains this year, but there could be a few untapped veins in this biotech gold mine. We'll need to tread lightly because a great deal of success is already baked into the price, but a few... Read more
28d
FOX Business
Why Exelixis, Inc. Could Be a Gold Mine for Growth InvestorsExelixis, Inc.(NASDAQ: EXEL) has already delivered big gains this year, but the
FOX Business / Posted 28 days ago
Exelixis, Inc.(NASDAQ: EXEL) has already delivered big gains this year, but there could be a few untapped veins in this biotech gold mine. We'll need to tread lightly because a great deal of success is already baked into the price, but a few... Read more
30d
Channel NewsAsia
Pfizer, Exelixis cancer drugs get FDA approval for wider useREUTERS: Cancer treatments from Pfizer Inc and Exelixis Inc on Tuesday won appr
Channel NewsAsia / Posted 30 days ago
REUTERS: Cancer treatments from Pfizer Inc and Exelixis Inc on Tuesday won approval from the U.S. Food and Drug Administration for expanded use in previously untreated patients. Pfizer's Bosulif was expanded to treat newly-diagnosed adult patients... Read more

In this news